Ayala Pharmaceuticals Inc (STU:FAD)
€ 0.01 -0.04 (-80%) Market Cap: 788,000.00 Enterprise Value: 3.88 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

Advaxis Inc Extraordinary Shareholders Meeting Transcript

Jan 13, 2023 / 03:00PM GMT
Release Date Price: €1.35
Operator

Good day, and welcome to the Advaxis, Inc. 2023 special meeting. I would now like to turn the conference over to Kenneth Berlin, President and Chief Executive Officer of Advaxis, Inc. Please go ahead.

Kenneth Berlin
Advaxis, Inc. - President and CEO

Good morning. I'm Kenneth Berlin, President and Chief Executive Officer of Advaxis, Inc. Welcome and thank you for joining us for the Special Meeting of Stockholders. Notice of the special meeting was filed with the SEC on December 13, 2022. Proof of notice will be incorporated into the minutes of this special meeting.

The Board has appointed Christopher J. Woods to act as the Inspector of Election for the meeting. The Inspector has determined that the holders of at least one-third of the shares of Advaxis common and preferred stock issued and outstanding entitled to vote at this meeting are represented in person or by proxy, and accordingly, a quorum for the meeting is present. A certified list of stockholders as of the record date is available by clicking Stockholder List located towards the bottom of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot